Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis

Multiple Sclerosis

Volumn 6, Issue 6, 2000, Pages 378-381

  Constantinescu, C S ^a,b   Freitag, P ^b   Kappos, L ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Glatiramer acetate; Multiple sclerosis; Peroxynitrite; Reactive nitrogen intermediates; Reactive oxygen intermediates; Uric acid

Indexed keywords

BETA1A INTERFERON; FREE RADICAL; GLATIRAMER; PEROXYNITRITE; URIC ACID;

ADULT; ALLERGIC ENCEPHALOMYELITIS; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INHIBITION; FEMALE; GOUT; HUMAN; MALE; MULTIPLE SCLEROSIS; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIOXIDANTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; URIC ACID;

EID: 0034490274     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800701566340     Document Type: Article

References (25)

1. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
2. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases
3. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
4. Peroxynitrite formation within the central nervous system in active multiple sclerosis
5. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis
6. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting MS: Results of a phase III multicenter, double-blind, placebo-controlled trial
7. New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis
8. Treatment of multiple sclerosis with copolymer-1 (copaxone): Implicating mechanisms of Th1 to Th2/Th3 immune-deviation
9. Effect of copolymer-1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis
10. Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS. Quantitative MR assessment
11. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
12. Defining the clinical course of multiple sclerosis: Results of an international survey
13. Uric acid levels in serum from patients with multiple sclerosis
14. Measurement of allantoin and uric acid in human body fluids: A potential index of free-radical reactions in vivo?
15. Purine nucleotide metabolism in resident and activated rat macrophages
16. Uricolysis by human leucocytes
17. Peroxynitrite-mediated tyrosine nitration catalysed by superoxide dismutase
18. Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by the extra virgin olive oil-derived antioxidant hydroxytyrosol
19. Demyelination: The role of reactive oxygen and nitrogen species
20. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
21. Therapy of human ovarian cancer by transfection with the murine interferon beta gene: Role of macrophage-inducible nitric oxide synthase
22. Pivotal role of Stat 1alpha in induction of the inducible nitric oxide synthase gene
23. Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line
24. Randomized, double-blind, placebo-controlled study of interferon-beta 1 a in relapsing-remitting multiple sclerosis